title: Erlotinib plus parenteral nutrition: an opportunity to get through the hardest days of advanced non-small cell lung cancer with cancer anorexia-cachexia syndrome.
abstract: This case study details the poor performance status of a patient with non-small cell lung cancer and cancer anorexia-cachexia syndrome got through the hardest days of high tumor burden and malnutrition, by using a combined therapy of lung cancer-targeted therapy drug and parenteral nutrition. The related literatures were reviewed.
authors: Department of Respiratory Medicine, Changzheng Hospital, Second Military Medical University/ Center for diagnosis and treatment of Lung Cancer of the Chinese Peoples's Liberation Army, Shanghai, China.
authors: Yuan-Sheng
authors: YS
authors: Zang
authors: Zheng
authors: Z
authors: Fang
authors: Bing
authors: B
authors: Li
mesh_terms: D000855:Anorexia / Q000209:etiology / Q000628:therapy*; D002100:Cachexia / Q000209:etiology / Q000628:therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications / Q000628:therapy*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010288:Parenteral Nutrition / Q000379:methods*; D011799:Quinazolines / Q000627:therapeutic use*; D013577:Syndrome
chemical_list: D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors